Haisco：CYPSEDO® Ciprofol received a US FDA marketing application.
Legend Biotech：LB2501 clinical data were disclosed.
Legend Biotech：Carvykti ciltacabtagene autoleucel is the best-selling cell therapy product in the world.
How much does Kisunla (Donanemab Injection) Cost& price without insurance in China?
Henlius：Pimurutamab Completed First Patient Dosing in China
Biogen：BIIB122 failed in Phase IIb clinical trial.
Bio-Dia：Amlodipine Besylate has been rejected again.
Hengrui：SHR4640 approved for marketing in China.
Northland：NL003 received marketing approval
JMT-Bio/Alphamab Oncology：Anbenitamab was approved
